Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ ¿©¼º¿¡¼­ ÁßÁõÀڱ󻸷Áõ°ú CYP1B1 À¯ÀüÀÚ ´ÙÇü¼º°úÀÇ °ü·Ã¼º¿¡ °üÇÑ ¿¬±¸ Association of the CYP1B1 Gene Polymorphism with the Risk of Advanced Endometriosis in Korean Women

´ëÇѺÒÀÓÇÐȸÁö 2006³â 33±Ç 2È£ p.85 ~ 95
Á¶¿¬Áø, Ç㼺Àº, ÀÌÁö¿µ, ¼ÛÀοÁ, ±Ã¹Ì°æ, ¹®Çý¼º, Á¤Çý¿ø,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶¿¬Áø ( Cho Yun-Jin ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ÀϺ´¿ø »êºÎÀΰú

Ç㼺Àº ( Hur Sung-Eun ) 
°Ç¾ç´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
ÀÌÁö¿µ ( Lee Ji-Young ) 
°Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
¼ÛÀοÁ ( Song In-Ok ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ÀϺ´¿ø »êºÎÀΰú
±Ã¹Ì°æ ( Koong Mi-Kyoung ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ÀϺ´¿ø »êºÎÀΰú
¹®Çý¼º ( Moon Hye-Sung ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
Á¤Çý¿ø ( Chung Hye-Won ) 
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Abstract

¸ñ Àû: CYP1B1Àº Àڱ󻸷ÁõÀÇ ¹ß»ý°ú °ü·ÃµÈ ¿¡½ºÆ®·Î°ÕÀÇ ´ë»ç ¹× dioxinÀÇ ´ë»ç ¸ðµÎ¿Í °ü·ÃÀÌ ÀÖ´Â À¯ÀüÀÚ·Î »ý°¢ÇÏ¿© Àڱ󻸷ÁõÀÇ ¹ß»ýÀ§Çè°ú CYP1B1ÀÇ codon 119G¡æT, 432G¡æC,449T¡æC, 453A¡æGÀÇ À¯ÀüÀÚ ´ÙÇü¼º°úÀÇ °ü°è¿¡ ´ëÇؼ­ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

¿¬±¸¹æ¹ý: º´¸®Á¶Á÷ÇÐÀûÀ¸·Î Àڱ󻸷Áõ III±â¿Í IV±âÀÓÀ» È®ÀÎÇÑ ¿©¼º 199¸í°ú ´ëÁ¶±ºÀ¸·Î Àڱ󻸷Áõ ȯÀÚ±º°ú ¿¬·ÉÀÌ ºñ½ÁÇÑ ¿©¼º¿¡¼­ ¾ç¼º ³­¼Ò ³¶Á¾À¸·Î ¼ö¼úÀ» ½ÃÇàÇÏ¿© Àڱ󻸷ÁõÀÌ ¾øÀ½À» À°¾ÈÀ¸·Î È®ÀÎÇÑ 183¸íÀ» ´ë»óÀ¸·Î PCR ¹× RFLP¸¦ ½ÃÇàÇÏ¿© CYP1B1ÀÇ codon 119G¡æT, 432C¡æG, 449T¡æC, 453A¡æGÀÇ ´ÙÇü¼ºÀ» Á¶»çÇÏ¿´´Ù.

°á °ú: CYP1B1¿¡¼­ Ala119Ser, Val432Leu, Asn449 (T449¡æC), Asn453Ser °¢°¢ÀÇ À¯ÀüÀÚ ´ÙÇü¼ºÀº ±× ºÐÆ÷¿Í À§Çèµµ¿¡ À־ Àڱ󻸷Áõ ȯÀÚ¿Í ´ëÁ¶±º °£¿¡ Åë°èÀûÀ¸·Î À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù. CYP1B1¿¡¼­ ¾Õ¼­ ¹àÈù 4°¡Áö codonÀÇ ´ÙÇü¼ºÀ» Á¶ÇÕÇÑ °á°ú GG/CC/CC/AAÀÇ À¯ÀüÀÚÇüÀ» °®´Â ¿©¼º¿¡ ºñÇØ GG/GC+GG/TC+TT/AAÀÇ À¯ÀüÀÚÇüÀ» °®´Â °æ¿ì¸¸ÀÌ Àڱ󻸷ÁõÀÇ À§Çèµµ°¡ 2.056 (95% CI: 1.003~4.216)À¸·Î À¯ÀÇÇÏ°Ô ³ôÀº °ÍÀ» ¾Ë ¼ö ÀÖ¾ú´Ù.

°á ·Ð: ÀÌ»óÀ¸·Î º¼ ¶§ Çѱ¹ÀÎ ¿©¼º¿¡¼­ ÁßÁõÀڱ󻸷Áõ ¹ß»ýÀº CYP1B1ÀÇ À¯ÀüÀû ´ÙÇü¼º°ú °ü·ÃÀÌ ÀÖ´Â °ÍÀ¸·Î º¸À̸ç, ÇâÈÄ Àڱ󻸷ÁõÀÇ ¹ß»ý ±âÀüÀ» ¹àÈ÷´Âµ¥ ÁÖ¿äÇÑ ÀÚ·á°¡ µÉ °ÍÀ¸·Î º»´Ù.

Objective: To investigate whether polymorphisms of gene encoding CYP1B1 is associated with the risk of endometriosis in Korean women.

Methods: We investigated 199 patients with histopathologically confirmed endometriosis rAFS stage III/IV and 183 control group women who were surgically proven to have no endometriosis. The genetic distribution of four different CYP1B1 polymorphisms at G119-T, G432-C, T449-C, and A453-G were analyzed by polymerase chain reaction (PCR) and restriction fragment length polymorphism of PCR products.

Results: We found no overall association between each individual CYP1B1 genotype and the risk of endometriosis. The odds ratio of genotype GG/GC+GG/TC+TT/AA compared to GG/CC/CC/AA (reference) was calculated as 2.06 with a 95% confidence interval of 1.003~4.216.
Conclusions: This results suggest that CYP1B1 genetic polymorphism may be associated with development of endometriosis in Korean women.

Å°¿öµå

Àڱ󻸷Áõ;CYP1B1;À¯ÀüÀÚ ´ÙÇü¼º
Endometriosis;CYP1B1;Genetic polymorphism

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS